P
Paracel Explorer
Dernière publication·Octobre 2026

Iopidine

Apraclonidinum — gtt opht 1 %

Essential Pharma Switzerland GmbH

ATCS01EA03
Swissmedic53737
Dossier17100
Remboursement
QP 10%
Modifications (11)